The Goldman Sachs Group Boosts Ionis Pharmaceuticals (NASDAQ:IONS) Price Target to $37.00
Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) had its target price increased by The Goldman Sachs Group from $33.00 to $37.00 in a report issued on Friday morning, Benzinga reports. The Goldman Sachs Group currently has a sell rating on the stock. Several other brokerages have also weighed in on IONS. Sanford C. Bernstein raised shares […]
More Stories
Flaherty & Crumrine Preferred Securities Income Fund Inc. (NYSE:FFC) Raises Dividend to $0.09 Per Share
Flaherty & Crumrine Preferred Securities Income Fund Inc. (NYSE:FFC – Get Free Report) announced a monthly dividend on Monday, July...
Genesis Energy Limited (GNE) to Issue Final Dividend of $0.06 on October 10th
Genesis Energy Limited (ASX:GNE – Get Free Report) announced a final dividend on Thursday, September 19th, MarketIndexAU reports. Investors of...
Finsbury Growth & Income (FGT) To Go Ex-Dividend on October 3rd
Finsbury Growth & Income (LON:FGT – Get Free Report) declared a dividend on Friday, September 20th, Upcoming.Co.Uk reports. Shareholders of...
Tasmea Limited (TEA) to Issue Final Dividend of $0.04 on October 16th
Tasmea Limited (ASX:TEA – Get Free Report) announced a final dividend on Friday, September 20th, MarketIndexAU reports. Investors of record...
Galaxy Entertainment Group Limited (OTCMKTS:GXYEF) Announces Dividend of $0.50
Galaxy Entertainment Group Limited (OTCMKTS:GXYEF – Get Free Report) announced a dividend on Friday, September 20th, investing.com reports. Shareholders of...
United States Steel (NYSE:X) Updates Q3 2024 Earnings Guidance
United States Steel (NYSE:X – Get Free Report) updated its third quarter 2024 earnings guidance on Thursday. The company provided...